nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoxetate—Gastric irritation—Hydrochlorothiazide—nephrolithiasis	0.048	0.0812	CcSEcCtD
Gadoxetate—Epigastric discomfort—Hydrochlorothiazide—nephrolithiasis	0.0354	0.0599	CcSEcCtD
Gadoxetate—Respiratory distress—Hydrochlorothiazide—nephrolithiasis	0.0293	0.0495	CcSEcCtD
Gadoxetate—Feeling hot—Hydrochlorothiazide—nephrolithiasis	0.0237	0.0401	CcSEcCtD
Gadoxetate—Blood urea increased—Hydrochlorothiazide—nephrolithiasis	0.0176	0.0297	CcSEcCtD
Gadoxetate—Swelling—Hydrochlorothiazide—nephrolithiasis	0.0153	0.0259	CcSEcCtD
Gadoxetate—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.0142	0.024	CcSEcCtD
Gadoxetate—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.013	0.0221	CcSEcCtD
Gadoxetate—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.0127	0.0214	CcSEcCtD
Gadoxetate—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.0123	0.0208	CcSEcCtD
Gadoxetate—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.0118	0.0199	CcSEcCtD
Gadoxetate—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.0117	0.0197	CcSEcCtD
Gadoxetate—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0174	CcSEcCtD
Gadoxetate—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0173	CcSEcCtD
Gadoxetate—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0173	CcSEcCtD
Gadoxetate—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0171	CcSEcCtD
Gadoxetate—SLCO1B3—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00989	0.0279	CbGpPWpGaD
Gadoxetate—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00937	0.0158	CcSEcCtD
Gadoxetate—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.0093	0.0157	CcSEcCtD
Gadoxetate—ABCC3—NRF2 pathway—SLC2A9—nephrolithiasis	0.00913	0.0258	CbGpPWpGaD
Gadoxetate—SLCO1B3—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00905	0.0255	CbGpPWpGaD
Gadoxetate—SLCO1B3—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00905	0.0255	CbGpPWpGaD
Gadoxetate—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00868	0.0147	CcSEcCtD
Gadoxetate—ABCC4—NRF2 pathway—SLC2A9—nephrolithiasis	0.00858	0.0242	CbGpPWpGaD
Gadoxetate—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00835	0.0141	CcSEcCtD
Gadoxetate—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00802	0.0136	CcSEcCtD
Gadoxetate—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00797	0.0135	CcSEcCtD
Gadoxetate—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00787	0.0133	CcSEcCtD
Gadoxetate—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00767	0.013	CcSEcCtD
Gadoxetate—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00763	0.0129	CcSEcCtD
Gadoxetate—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00755	0.0128	CcSEcCtD
Gadoxetate—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00748	0.0126	CcSEcCtD
Gadoxetate—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00734	0.0124	CcSEcCtD
Gadoxetate—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00731	0.0124	CcSEcCtD
Gadoxetate—Syncope—Hydrochlorothiazide—nephrolithiasis	0.0073	0.0123	CcSEcCtD
Gadoxetate—ABCC2—NRF2 pathway—SLC2A9—nephrolithiasis	0.00724	0.0204	CbGpPWpGaD
Gadoxetate—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00719	0.0122	CcSEcCtD
Gadoxetate—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00715	0.0121	CcSEcCtD
Gadoxetate—Cough—Hydrochlorothiazide—nephrolithiasis	0.0071	0.012	CcSEcCtD
Gadoxetate—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00693	0.0117	CcSEcCtD
Gadoxetate—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00691	0.0117	CcSEcCtD
Gadoxetate—SLCO1B3—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00686	0.0194	CbGpPWpGaD
Gadoxetate—SLCO1B3—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00686	0.0194	CbGpPWpGaD
Gadoxetate—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00685	0.0116	CcSEcCtD
Gadoxetate—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00678	0.0115	CcSEcCtD
Gadoxetate—SLCO1B1—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00665	0.0188	CbGpPWpGaD
Gadoxetate—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00664	0.0112	CcSEcCtD
Gadoxetate—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00664	0.0112	CcSEcCtD
Gadoxetate—Shock—Hydrochlorothiazide—nephrolithiasis	0.00654	0.011	CcSEcCtD
Gadoxetate—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00648	0.011	CcSEcCtD
Gadoxetate—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00642	0.0109	CcSEcCtD
Gadoxetate—SLCO1B3—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00638	0.018	CbGpPWpGaD
Gadoxetate—SLCO1B3—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00638	0.018	CbGpPWpGaD
Gadoxetate—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00633	0.0107	CcSEcCtD
Gadoxetate—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00621	0.0105	CcSEcCtD
Gadoxetate—SLCO1B1—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00608	0.0172	CbGpPWpGaD
Gadoxetate—SLCO1B1—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00608	0.0172	CbGpPWpGaD
Gadoxetate—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00596	0.0101	CcSEcCtD
Gadoxetate—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00592	0.01	CcSEcCtD
Gadoxetate—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00577	0.00976	CcSEcCtD
Gadoxetate—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00573	0.00968	CcSEcCtD
Gadoxetate—SLCO1B3—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00568	0.016	CbGpPWpGaD
Gadoxetate—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00568	0.0096	CcSEcCtD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00564	0.0159	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00564	0.0159	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.00549	0.0155	CbGpPWpGaD
Gadoxetate—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00547	0.00925	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00543	0.00918	CcSEcCtD
Gadoxetate—SLCO1B1—renal system—nephrolithiasis	0.00541	0.0999	CbGeAlD
Gadoxetate—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00528	0.00892	CcSEcCtD
Gadoxetate—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00525	0.00888	CcSEcCtD
Gadoxetate—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00525	0.00888	CcSEcCtD
Gadoxetate—SLCO1B1—kidney—nephrolithiasis	0.00523	0.0966	CbGeAlD
Gadoxetate—ABCC3—renal system—nephrolithiasis	0.00513	0.0948	CbGeAlD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00509	0.0144	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00509	0.0144	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00503	0.0142	CbGpPWpGaD
Gadoxetate—ABCC3—kidney—nephrolithiasis	0.00496	0.0916	CbGeAlD
Gadoxetate—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00489	0.00827	CcSEcCtD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00479	0.0135	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00479	0.0135	CbGpPWpGaD
Gadoxetate—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00477	0.00806	CcSEcCtD
Gadoxetate—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.0047	0.00794	CcSEcCtD
Gadoxetate—ABCC4—nephron tubule—nephrolithiasis	0.00466	0.0861	CbGeAlD
Gadoxetate—SLCO1B1—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00461	0.013	CbGpPWpGaD
Gadoxetate—SLCO1B1—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00461	0.013	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.0046	0.013	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.0046	0.013	CbGpPWpGaD
Gadoxetate—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00455	0.00768	CcSEcCtD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00454	0.0128	CbGpPWpGaD
Gadoxetate—ABCC2—nephron tubule—nephrolithiasis	0.00451	0.0833	CbGeAlD
Gadoxetate—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00439	0.00742	CcSEcCtD
Gadoxetate—SLCO1B1—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00428	0.0121	CbGpPWpGaD
Gadoxetate—SLCO1B1—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00428	0.0121	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00427	0.012	CbGpPWpGaD
Gadoxetate—ABCC4—renal system—nephrolithiasis	0.00423	0.0782	CbGeAlD
Gadoxetate—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00422	0.00714	CcSEcCtD
Gadoxetate—Rash—Hydrochlorothiazide—nephrolithiasis	0.00419	0.00708	CcSEcCtD
Gadoxetate—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00418	0.00707	CcSEcCtD
Gadoxetate—Headache—Hydrochlorothiazide—nephrolithiasis	0.00416	0.00703	CcSEcCtD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00415	0.0117	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00415	0.0117	CbGpPWpGaD
Gadoxetate—ABCC2—renal system—nephrolithiasis	0.0041	0.0757	CbGeAlD
Gadoxetate—ABCC4—kidney—nephrolithiasis	0.00409	0.0756	CbGeAlD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00404	0.0114	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00404	0.0114	CbGpPWpGaD
Gadoxetate—ABCC4—cortex of kidney—nephrolithiasis	0.00399	0.0737	CbGeAlD
Gadoxetate—ABCC2—kidney—nephrolithiasis	0.00396	0.0732	CbGeAlD
Gadoxetate—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00395	0.00667	CcSEcCtD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.0039	0.011	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.0039	0.011	CbGpPWpGaD
Gadoxetate—ABCC2—cortex of kidney—nephrolithiasis	0.00386	0.0713	CbGeAlD
Gadoxetate—SLCO1B1—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00382	0.0108	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00379	0.0107	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00379	0.0107	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.0036	0.0102	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00349	0.00984	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00349	0.00984	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00338	0.00954	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00329	0.00929	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00329	0.00929	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00324	0.00915	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00324	0.00915	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00314	0.00888	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00314	0.00888	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00309	0.00872	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00309	0.00872	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00296	0.00835	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00296	0.00835	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00292	0.00825	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00292	0.00825	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00289	0.00815	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00289	0.00815	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—SLC7A9—nephrolithiasis	0.00283	0.00799	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—DGKH—nephrolithiasis	0.00283	0.00799	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00275	0.00776	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00275	0.00776	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00261	0.00736	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00261	0.00736	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00249	0.00704	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00249	0.00704	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00245	0.00692	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00245	0.00692	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00234	0.00661	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00234	0.00661	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00232	0.00654	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00232	0.00654	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00231	0.00652	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00218	0.00615	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00218	0.00615	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00208	0.00588	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00207	0.00583	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00207	0.00583	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GRHPR—nephrolithiasis	0.002	0.00565	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00196	0.00553	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00194	0.00548	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00194	0.00548	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GRHPR—nephrolithiasis	0.00181	0.0051	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—AGXT—nephrolithiasis	0.00178	0.00504	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00165	0.00466	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—AGXT—nephrolithiasis	0.00161	0.00455	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00155	0.00438	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—APRT—nephrolithiasis	0.00152	0.00428	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—SLC26A1—nephrolithiasis	0.00152	0.00428	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—APRT—nephrolithiasis	0.00137	0.00387	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—SLC26A1—nephrolithiasis	0.00137	0.00387	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GRHPR—nephrolithiasis	0.00135	0.0038	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—AGXT—nephrolithiasis	0.0012	0.00339	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—AQP1—nephrolithiasis	0.00108	0.00305	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—SLC26A1—nephrolithiasis	0.00102	0.00288	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—APRT—nephrolithiasis	0.00102	0.00288	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CHRM3—nephrolithiasis	0.000978	0.00276	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—AQP1—nephrolithiasis	0.000976	0.00275	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CHRM3—nephrolithiasis	0.000882	0.00249	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—AQP1—nephrolithiasis	0.000727	0.00205	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CHRM3—nephrolithiasis	0.000657	0.00185	CbGpPWpGaD
